Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-16

FDA Approved: BRIMONIDINE TARTRATE/TIMOLOL MALEATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's generic fixed-dose combination eye drops containing brimonidine tartrate and timolol maleate for reducing intraocular pressure in open-a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIMONIDINE TARTRATE/TIMOLOL MALEATE (BRIMONIDINE TARTRATE AND TIMOLOL MALEATE)

Snippet

ORIG AP for BRIMONIDINE TARTRATE/TIMOLOL MALEATE (BRIMONIDINE TARTRATE AND TIMOLOL MALEATE)